BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23958951)

  • 1. Identification of a cellular ligand for the natural cytotoxicity receptor NKp44.
    Baychelier F; Sennepin A; Ermonval M; Dorgham K; Debré P; Vieillard V
    Blood; 2013 Oct; 122(17):2935-42. PubMed ID: 23958951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans.
    Parodi M; Favoreel H; Candiano G; Gaggero S; Sivori S; Mingari MC; Moretta L; Vitale M; Cantoni C
    Front Immunol; 2019; 10():719. PubMed ID: 31024551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Found: a cellular activating ligand for NKp44.
    Rajagopalan S; Long EO
    Blood; 2013 Oct; 122(17):2921-2. PubMed ID: 24159160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells.
    Fausther-Bovendo H; Sol-Foulon N; Candotti D; Agut H; Schwartz O; Debré P; Vieillard V
    AIDS; 2009 Jun; 23(9):1077-87. PubMed ID: 19424050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel ligand on astrocytes interacts with natural cytotoxicity receptor NKp44 regulating immune response mediated by NK cells.
    Bowen KE; Mathew SO; Borgmann K; Ghorpade A; Mathew PA
    PLoS One; 2018; 13(2):e0193008. PubMed ID: 29447242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive expression of ligand for natural killer cell NKp44 receptor (NKp44L) by normal human articular chondrocytes.
    Białoszewska A; Baychelier F; Niderla-Bielińska J; Czop A; Debré P; Vieillard V; Kieda C; Malejczyk J
    Cell Immunol; 2013; 285(1-2):6-9. PubMed ID: 24044960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand.
    Vieillard V; Strominger JL; Debré P
    Proc Natl Acad Sci U S A; 2005 Aug; 102(31):10981-6. PubMed ID: 16046540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection.
    Vieillard V; Costagliola D; Simon A; Debré P;
    AIDS; 2006 Sep; 20(14):1795-804. PubMed ID: 16954720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis.
    Vitale M; Bottino C; Sivori S; Sanseverino L; Castriconi R; Marcenaro E; Augugliaro R; Moretta L; Moretta A
    J Exp Med; 1998 Jun; 187(12):2065-72. PubMed ID: 9625766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Natural Cytotoxicity Receptor NKp44 (NCR2, CD336) Is Expressed on the Majority of Porcine NK Cells
    Mair KH; Crossman AJ; Wagner B; Babasyan S; Noronha L; Boyd P; Zarlenga D; Stadler M; van Dongen KA; Gerner W; Saalmüller A; Lunney JK
    Front Immunol; 2022; 13():767530. PubMed ID: 35154097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR5 or CXCR4 use influences the relationship between CD4 cell depletion, NKp44L expression and NK cytotoxicity in SHIV-infected macaques.
    Vieillard V; Habib RE; Brochard P; Delache B; Bovendo HF; Calvo J; Morin J; Picq I; Martinon F; Vaslin B; Le Grand R; Debré P
    AIDS; 2008 Jan; 22(2):185-92. PubMed ID: 18097220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NKp44 triggers NK cell activation through DAP12 association that is not influenced by a putative cytoplasmic inhibitory sequence.
    Campbell KS; Yusa S; Kikuchi-Maki A; Catina TL
    J Immunol; 2004 Jan; 172(2):899-906. PubMed ID: 14707061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily.
    Cantoni C; Bottino C; Vitale M; Pessino A; Augugliaro R; Malaspina A; Parolini S; Moretta L; Moretta A; Biassoni R
    J Exp Med; 1999 Mar; 189(5):787-96. PubMed ID: 10049942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44.
    Rosental B; Brusilovsky M; Hadad U; Oz D; Appel MY; Afergan F; Yossef R; Rosenberg LA; Aharoni A; Cerwenka A; Campbell KS; Braiman A; Porgador A
    J Immunol; 2011 Dec; 187(11):5693-702. PubMed ID: 22021614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions.
    Kopp LM; Ray A; Denman CJ; Senyukov VS; Somanchi SS; Zhu S; Lee DA
    Mol Immunol; 2013 Jul; 54(3-4):296-301. PubMed ID: 23328088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Natural Cytotoxicity Receptors in Health and Disease.
    Barrow AD; Martin CJ; Colonna M
    Front Immunol; 2019; 10():909. PubMed ID: 31134055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous and natural cytotoxicity receptor-mediated cytotoxicity are effector functions of distinct natural killer subsets in hepatitis C virus-infected chimpanzees.
    Verstrepen BE; Nieuwenhuis IG; Mooij P; Bogers WM; Boonstra A; Koopman G
    Clin Exp Immunol; 2016 Jul; 185(1):42-9. PubMed ID: 26850369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human NK cytotoxicity against porcine cells is triggered by NKp44 and NKG2D.
    Forte P; Lilienfeld BG; Baumann BC; Seebach JD
    J Immunol; 2005 Oct; 175(8):5463-70. PubMed ID: 16210654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of human NK cell reactivity using latex beads coated with defined amounts of antibodies.
    Dorsch M; Urlaub D; Bönnemann V; Bröde P; Sandusky M; Watzl C
    Eur J Immunol; 2020 May; 50(5):656-665. PubMed ID: 32027754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules.
    Tallerico R; Todaro M; Di Franco S; Maccalli C; Garofalo C; Sottile R; Palmieri C; Tirinato L; Pangigadde PN; La Rocca R; Mandelboim O; Stassi G; Di Fabrizio E; Parmiani G; Moretta A; Dieli F; Kärre K; Carbone E
    J Immunol; 2013 Mar; 190(5):2381-90. PubMed ID: 23345327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.